Showing 3131-3140 of 5956 results for "".
- HelpMeSee Eye Surgery Simulator Demonstrations Scheduled for the 2018 World Ophthalmology Conference in Barcelonahttps://modernod.com/news/helpmesee-eye-surgery-simulator-demonstrations-scheduled-for-the-2018-world-ophthalmology-conference-in-barcelona/2480099/HelpMeSee is presenting their Eye Surgery Simulator and companion eBook for teaching manual small incision cataract surgery (MSICS) at the International Council of Ophthalmology’s (ICO) 2018 World Ophthalmology Conference (WOC) in Barcelona, Spain. WOC attendees interested in scheduling dem
- CMS Issues Preliminary Decision on Unique J Code for Avedro Photrexa Drug Formulationshttps://modernod.com/news/cms-issues-preliminary-decision-on-unique-j-code-for-avedro-photrexa-drug-formulations/2480101/Avedro announced that the Centers for Medicare and Medicaid Services (CMS) has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System (HCPCS) J code for Photrexa drug formulations. Claims submitted with a product specific J code are generally proce
- Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Deliveryhttps://modernod.com/news/eyenovia-receives-notices-of-allowance-from-uspto-on-two-additional-patent-applications-for-ophthalmic-drug-delivery/2480109/Eyenovia announced it has received Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for two additional patent applications. The allowed patents provide fundamental coverage on physiologic microdroplet ejection diameters and velocities, which enable gentle delivery of ophthal
- Alcon Launches New Multifocal Advertising Campaign to Increase Awareness of Contact Lens Optionshttps://modernod.com/news/alcon-launches-new-multifocal-advertising-campaign-to-increase-awareness-of-contact-lens-options/2480111/Alcon has launched its “See Near and Far” direct-to-consumer campaign to increase consumer awareness of multifocal contact lens options and encourage them to visit an eye care professional (ECP). The campaign will include a television spot that will run on ABC, NBC, CBS, and ESPN, among others, t
- Chinese Researchers Use Waste Corneal Lenses to Treat Eye Diseasehttps://modernod.com/news/chinese-researchers-use-waste-corneal-lenses-to-treat-eye-disease/2480118/Chinese researchers are celebrating a breakthrough in the treatment of eye disease by using “waste” corneal lenses after laser surgery for near- and far-sightedness, according to a report in XinhuaNet. A
- BioTime Announces $1.9 Million Grant for Continued Development of OpRegen for Dry-AMDhttps://modernod.com/news/biotime-announces-1-9-million-grant-for-continued-development-of-opregen-for-dry-amd/2480136/BioTime has been awarded a new grant for 2018 of up to 6.9 million Israeli New Shekels (approximately $1.9 million) from the Israel Innovation Authority (IIA). The grant provides funding for the continued development of OpRegen, and to date the IIA has provided annual grants totaling over $13 mil
- Telescope Implant for End-State Macular Degeneration Now on the Federal Supply Schedule and Available at VA Hospitalshttps://modernod.com/news/telescope-implant-for-end-state-macular-degeneration-now-on-the-federal-supply-schedule-and-available-at-va-hospitals/2480149/VisionCare announced that MellingMedical will distribute the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to Department of Veteran’s Affairs hospitals, military hospitals, and other federal government healthcare facilities in the United States. MellingMedical provides medical su
- First Series C-Round Closing for Medical Device Company Implandata Ophthalmic Productshttps://modernod.com/news/first-series-c-round-closing-for-medical-device-company-implandata-ophthalmic-products/2480150/Ophthalmic medical device company Implandata Ophthalmic Products announced that the company accomplished a first closing of its Series C funding round. The company was able to raise a “mid-single digit million Euro” amount from a strategic and several institutional and private investo
- Bausch + Lomb Initiates Clinical Trial Evaluating New Ophthalmic Viscosurgical Devicehttps://modernod.com/news/bausch-lomb-initiates-clinical-trial-evaluating-new-ophthalmic-viscosurgical-device/2480163/Bausch + Lomb announced that it has initiated a clinical trial evaluating the safety and efficacy of a new ophthalmic viscosurgical device (OVD). Bausch + Lomb aims to file for premarket approval (PMA) with the FDA at the conclusion of the clinical trial, with plans to bring this next-generation
- LayerBio Awarded $1.2 Million from NIH to Develop Sustained-Release Glaucoma Drughttps://modernod.com/news/layerbio-awarded-1-2-million-from-nih-to-develop-sustained-release-glaucoma-drug/2480164/Founded in 2013 as a spin-off from the lab of Dr. Paula Hammond at MIT, LayerBio is developing novel drug delivery products for ophthalmology, wound care, tendon repair and other unmet medical needs. The National Eye Institute at the National I